GTS Securities’s T-REX 2X Inverse CRCL Daily Target ETF CRCD Stock Holding History

GTS Securities’s Portfolio CRCD Stock Details CRCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-15,929	Closed	-$349K	–	1930
2025 Q3	$349K	Buy	+15,929	New	+$358K	0.01%	943

Other funds holding CRCD

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

GTS Securities's CRCD Position: Q4 2025 in Review

GTS Securities sold out of T-REX 2X Inverse CRCL Daily Target ETF (CRCD) in Q4 2025, closing a stake of 15,929 shares — an estimated $349K sold.

GTS Securities first reported a position in CRCD in Q3 2025 and held it in 1 quarter. The position peaked at $349K in Q3 2025. 5 funds tracked by Wall St. Rank hold CRCD as of Q4 2025.

GTS Securities reported no remaining T-REX 2X Inverse CRCL Daily Target ETF position as of Q4 2025 after selling out during the quarter.
GTS Securities sold 15,929 T-REX 2X Inverse CRCL Daily Target ETF shares in Q4 2025, an estimated $349K.
GTS Securities first reported a position in T-REX 2X Inverse CRCL Daily Target ETF in Q3 2025 and held it in 1 quarter.
GTS Securities's T-REX 2X Inverse CRCL Daily Target ETF position peaked at $349K in Q3 2025.
5 funds tracked by Wall St. Rank held T-REX 2X Inverse CRCL Daily Target ETF as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.